Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy: An Open-Label Pilot Study

By Nigishi Hotta   Keigo Yasuda  

Clinical Drug Investigation, Vol. 24, Iss. 11, 2004-01 ,pp. : 671-680

Adis International

Access to resources Recommend Favorite

Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice

By  

Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. : 905-911

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of uptake carrier blockers SK & F 89976-A and l-trans-PDC on in vivo release of amino acids in rat hippocampus

By Zuiderwijk M.   Veenstra E.   Lopes da Silva F.H.   Ghijsen W.E.J.M.  

European Journal of Pharmacology, Vol. 307, Iss. 3, 1996-07 ,pp. : 275-282

Elsevier

Access to resources Recommend Favorite

Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries

By Edvinsson L.   Sams A.   Jansen-Olesen I.   Tajti J.   Kane S.A.   Rutledge R.Z.   Koblan K.S.   Hill R.G.   Longmore J.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Apamin-sensitive SK Ca channels modulate adrenal catecholamine release in anesthetized dogs

By Nagayama T.   Koshika T.   Hisa H.   Kimura T.   Satoh S.  

European Journal of Pharmacology, Vol. 327, Iss. 2, 1997-05 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite